Levine Media Group
August 9, 2021
United Soybean Board Awards $1 Million to Amfora to Continue Development of High-Protein Soy
Award reflects effort to maintain U.S. soy farmers’ global market share
SAN FRANCISCO, August 9, 2021 -- The United Soybean Board awarded $1 million to Amfora, Inc., a biotechnology company that is applying gene editing to sustainably feed the planet, to continue the development of soybean varieties with increased protein content.
July 21, 2021
Amfora Expands Series B Venture Round with New Investment from BayWa
SAN FRANCISCO, July 21, 2021 -- Amfora, Inc., a biotechnology company that is using gene editing to increase the protein density of soybean and other crops to fuel the plant-based protein revolution, announced an expansion to its Series B round to a total of $7 million with new investment from the global player and stock listed company BayWa AG.
March 23, 2021
Amfora Raises $6 Million with Investment from Leaps by Bayer and Spruce Capital Partners
SAN FRANCISCO, March 23, 2021 -- Amfora, Inc., a biotechnology company that is using gene editing to increase the protein density of soybean and other crops to fuel the plant-based protein revolution, announced that Leaps by Bayer and Spruce Capital Partners invested $6 million in its Series B financing round.
April 2, 2019
Amfora Licenses Gene Editing Technology
SAN FRANCISCO, April 02, 2019 -- Today Amfora, a biotechnology company, announced it has reached a non-exclusive research and commercial license agreement with Corteva Agriscience™, the Agriculture Division of DowDuPont™, and the Broad Institute of MIT and Harvard. Through the agreement, Amfora will use intellectual property covering CRISPR-Cas9 and related gene editing tools to develop a portfolio of gene-edited crops with increased protein content.
March 24, 2021
Amfora gets $6m Series B injection from Bayer, Spruce Capital to increase protein in crops
US foodtech startup Amfora has raised $6 million in Series B funding from San Francisco VC firm Spruce Capital Partners and Leaps by Bayer, the corporate venture arm of German life sciences giant Bayer.
August 14, 2020
Gene Editing Meets Supermarket Shelves
Many customers want to eat better, and CPG companies are constantly introducing new products to align with every new fad and trend out there, from keto to super carb and everything in between.
April 19, 2019
Amfora Licenses Gene Editing Tech in High-Protein Soy Work
Amfora signs agreement to use Cas9 in its ongoing work to generate a high-protein soybean variety for use as an aquafeed ingredient, says CEO